The severity of COVID-19 in children on immunosuppressive medication: The Lancet Child and Adolescent Health

M. Marlais, T. Wlodkowski, M. Vivarelli, L. Pape, B. Tönshoff, F. Schaefer, K. Tullus

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e17-e18
JournalLancet Child Adolesc. Health
Volume4
Issue number7
DOIs
Publication statusPublished - 2020

Keywords

  • adalimumab
  • azathioprine
  • basiliximab
  • cyclophosphamide
  • cyclosporine
  • eculizumab
  • everolimus
  • glucocorticoid
  • mycophenolate mofetil
  • rituximab
  • tacrolimus
  • immunosuppressive agent
  • adolescent
  • child
  • childhood
  • clinical article
  • comorbidity
  • coronavirus disease 2019
  • disease course
  • disease severity
  • female
  • human
  • immunity
  • immunosuppressive treatment
  • incidence
  • inflammatory bowel disease
  • intensive care
  • kidney disease
  • kidney transplantation
  • Letter
  • male
  • Betacoronavirus
  • child welfare
  • chronic kidney failure
  • complication
  • Coronavirus infection
  • Italy
  • pandemic
  • virus pneumonia
  • Adolescent
  • Child
  • Child Welfare
  • Coronavirus Infections
  • Female
  • Humans
  • Immunosuppressive Agents
  • Male
  • Pandemics
  • Pneumonia, Viral
  • Renal Insufficiency, Chronic

Cite this